Position in INSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,128,782
+$1,962,505 QoQ
Shares Held
104,378
+86.2% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#156
of 663 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Derivatives in INSM
reported options exposure · as of Sep 30, 2024CallValue
$1,321,300
CallShares
18,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. INSM ranks #8 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
This page
|
104,378 | $11,128,782 |
All Filings in INSM
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,128,782 | 104,378 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,166,277 | 56,056 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $8,732,046 | 60,635 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,397,300 | 83,439 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,237,500 | 16,221 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $570,270 | 8,260 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,907,736 | 39,832 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $1,321,300 | 18,100 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $5,224,124 | 77,972 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,035,875 | 369,918 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,459,800 | 79,374 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,135,850 | 203,400 | Shares | Sole | 2023-11-14 | |
| 2023-03-31 | $642,120 | 37,661 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $201,798 | 10,100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $497,121 | 23,079 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,286,098 | 65,218 | Shares | Sole | 2022-08-15 | |
| 2020-12-31 | $759,245 | 22,807 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $361,317 | 11,242 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||